GSK Update: ESMA Guidelines on performance fees in UCITS and certain types of AIFs

By Beate Dünschede for GSK Stockmann, April 20 2020
Back to news list

The European Securities and Markets Authority published its final report on the guidelines on performance fees in UCITS and certain types of AIFs on 3 April 2020 (the “Guidelines”).

Related news